Seeing more in expansion microscopy
New methods light up lipid membranes and let researchers see sets of proteins inside cells with high resolution.
New methods light up lipid membranes and let researchers see sets of proteins inside cells with high resolution.
FragFold, developed by MIT Biology researchers, is a computational method with potential for impact on biological research and therapeutic applications.
Whitehead Institute and CSAIL researchers created a machine-learning model to predict and generate protein localization, with implications for understanding and remedying disease.
Studying the pathogen R. parkeri, researchers discovered the first evidence of extensive and stable interkingdom contacts between a pathogen and a eukaryotic organelle.
New findings illuminate how Prochlorococcus’ nightly “cross-feeding” plays a role in regulating the ocean’s capacity to cycle and store carbon.
As part of a high-resolution biosensing device without wires, the antennas could help researchers decode intricate electrical signals sent by cells.
Chronic diseases like diabetes are prevalent, costly, and challenging to treat. A common denominator driving them may be a promising new therapeutic target.
By examining antigen architectures, MIT researchers built a therapeutic cancer vaccine that may improve tumor response to immune checkpoint blockade treatments.
New research reveals what it takes for a protein that is best known for protecting cells against death to take on the opposite role.
The findings suggest that biochemical and physical effects of exercise could help heal nerves.
By sidestepping the need for costly interventions, a new method could potentially reveal gene regulatory programs, paving the way for targeted treatments.
By snugly wrapping around neurons, these devices could help scientists probe subcellular regions of the brain, and might even help restore some brain function.
SMART researchers find mesenchymal stromal cells are an attractive alternative to current costly, time-intensive treatments.
Novel method to scale phenotypic drug screening drastically reduces the number of input samples, costs, and labor required to execute a screen.
A research scientist and internationally recognized authority in the field of blood cell development reflects on 45 years at MIT.